Hugel

Hugel R&D / Revenue

The R&D to Revenue Ratio of Hugel (145020.KQ) as of Oct 30, 2026 is 2.75 %. In the previous year, R&D to Revenue Ratio was 2.47 % — a change of 11.49% (higher).

R&D / Revenue

2.75 %

YoY

11.49%

Last updated:

R&D to Revenue Ratio of Hugel is 2025 2.75 % . R&D to Revenue Ratio of Hugel was 2024 2.47 % . It decreases by 11.49% higher compared to the previous year.

The Hugel R&D / Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D / Revenue
Date
R&D / Revenue
Jan 1, 2017
3.80 KRW
Jan 1, 2018
4.25 KRW
Jan 1, 2020
7.46 KRW
Jan 1, 2021
5.15 KRW
Jan 1, 2022
5.35 KRW
Jan 1, 2023
3.45 KRW
Jan 1, 2024
2.47 KRW
Jan 1, 2025
2.75 KRW
The Hugel R&D / Revenue history
YEARR&D / RevenueYoY
2.75 %+11.49%
2.47 %-28.36%
3.45 %-35.63%
5.35 %+3.95%
5.15 %-30.96%
7.46 %+75.54%
4.25 %+11.77%
3.80 %+16.15%
3.27 %-32.52%
4.85 %+0.80%
4.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hugel Stock analysis

What does Hugel do? Hugel Inc generates revenue by manufacturing and selling biopharmaceuticals based on clostridium botulinum, with products distributed in both domestic and overseas markets. The company’s portfolio includes botulinum toxins available in 50 unit types, 100 unit types, and 200unit types for treating benign essential blepharospasm and improving moderate to severe glabellar lines. Additionally, the firm offers hyaluronic acid fillers designed for the temporary removal of facial wrinkles, specifically the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m, the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A, and the chaeum VOLUS 20A. Beyond these medical aesthetics, the business also sells wellages, blue roses, and other cosmetics to its customer base. Hugel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hugel stock

R&D to Revenue Ratio of Hugel is 2.75 % in 2025.

R&D to Revenue Ratio of Hugel changed from 2.47 % to 2.75 %, representing a 11.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D to Revenue Ratio Hugel since 2006 – with annual values, charts, and detailed analysis.

The R&D to Revenue ratio shows what percentage of revenue a company invests in research and development. Higher ratios indicate stronger focus on innovation.

A 'good' varies by industry and company stage. On Eulerpool, you can compare R&D to Revenue Ratio's Hugel with sector peers and the industry average to assess whether it is attractive.

To evaluate R&D to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for R&D to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Hugel

All Key Metrics — Hugel